12-32802402-C-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001005242.3(PKP2):c.2167+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000041 in 1,461,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001005242.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461714Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727168
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Arrhythmogenic right ventricular cardiomyopathy Pathogenic:2
This variant disrupts a canonical splice site and is predicted to result in abnormal splicing. Aberrant splicing and/or loss of function is an established mechanism of disease. This prediction has not been confirmed by functional studies. This variant has been reported in at least two patients with cardiac arrest and/or referred to an inherited arrhythmia clinic (PMID: 26743238, 36138163). The PKP2 c.2299+1G>A variant co-occurred with a pathogenic DSG2 variant in one proband and with a MYH11 variant of uncertain significance in another proband, and it was observed in several asymptomatic family members (PMID: 36138163). The PKP2 c.2299+1G>A variant is absent from large population databases, including the Genome Aggregation Database (http://gnomad.broadinstitute.org/). -
The c.2299+1G>A variant in PKP2 has not been previously reported in individuals with cardiomyopathy or in large population studies, but has been reported in ClinVar (Variation ID: 202005). This variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and is predicted to cause altered splicing leading to an abnormal or absent protein. Splicing variants and other truncating variants in PKP2 are an established disease mechanism in ARVC. In summary, although additional studies are required to fully establish its clinical significance, the c.2299+1G>A variant is likely pathogenic. -
not provided Pathogenic:2
c.2299+1 G>A: IVS11+1 G>A in intron 11 of the PKP2 gene (NM_004572.3). The c.2299+1 G>A mutation in the PKP2 gene has also not been reported previously as a disease-causing mutation, however this mutation destroys the consensus splice donor site of intron 11 and is expected to cause abnormal gene splicing. Three splice prediction algorithms concur that c.2299+1 G>A results in the loss of the normal splice donor site. This mutation is predicted to lead to either an abnormal message, which is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. In addition, other splice site mutations (c.2489+1 G>A, c.2489+4 C>A) in the PKP2 gene have been reported in association with ARVC (Van der Zwaag P et al., 2009). Therefore, c.2299+1 G>A in the PKP2 gene is interpreted to be a disease-causing mutation. The variant is found in ARVC panel(s). -
- -
Arrhythmogenic right ventricular dysplasia 9 Pathogenic:1
This sequence change affects a donor splice site in intron 11 of the PKP2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PKP2 are known to be pathogenic (PMID: 15489853, 17041889, 23911551). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with arrhythmogenic right ventricular cardiomyopathy (PMID: 26743238, 36138163). ClinVar contains an entry for this variant (Variation ID: 202005). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Cardiomyopathy Pathogenic:1
This variant causes a G to A nucleotide substitution at the +1 position of intron 11 of the PKP2 gene. Splice site prediction tools predict that this variant may have a significant impact on RNA splicing. Although this prediction has not been confirmed in published RNA studies, this variant is expected to result in an absent or disrupted protein product. This variant has been reported in a few individuals affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 26743238, 36138163). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of PKP2 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Likely Pathogenic. -
Cardiovascular phenotype Pathogenic:1
The c.2299+1G>A intronic variant results from a G to A substitution one nucleotide after coding exon 11 of the PKP2 gene. This variant was reported in individuals with features consistent with arrhythmogenic right ventricular cardiomyopathy (ARVC); however, details were limited (Adler A et al. Circ Arrhythm Electrophysiol. 2016;9:e003440). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at